Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis

Bioorganic Chemistry(2025)10.1016/j.bioorg.2025.109190Source: DataRank Database

Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis is a research paper published in Bioorganic Chemistry (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: hybridTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Pedro Soares ORCID,Jose Ricardo D. dos Remedios ORCID,Raghad Nowar,Susan G. Fox,Anan Yu

Live enrichment

PubMed:41223590 PMC:PMC12648443 OpenAlex:https://openalex.org/W4415778244

National Institutes of Health

Grant: R01 AG061708

National Science Foundation

Grant: NNCI-1542205

International Institute for Nanotechnology, Northwestern University

Les Turner ALS Foundation

Hevolution Foundation

Northwestern University

FWCI

0.00

Citation Percentile

0.4%

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bioorg.2025.109190

publisherhttps://doi.org/10.1016/j.bioorg.2025.109190

publisherhttps://api.elsevier.com/content/article/PII:S0045206825010703?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0045206825010703?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41223590

Fields of Study

Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesNeurogenetic and Muscular Disorders Research

MeSH Terms

Superoxide Dismutase-1Amyotrophic Lateral SclerosisAnimalsDose-Response Relationship, DrugHumansStructure-Activity RelationshipMolecular StructurePC12 CellsRatsProtein Aggregation, PathologicalProtein Aggregates

Keywords

Amyotrophic lateral sclerosisIn vitroCellular modelIn vivoProtein aggregationPotencyStructure–activity relationshipSod-1Small-moleculesCyclohexane-1,3-diones

Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis

FAIR Checklist

Authors (9)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)